Fresenius Medical Care AG banner

Fresenius Medical Care AG
XMUN:FME

Watchlist Manager
Fresenius Medical Care AG Logo
Fresenius Medical Care AG
XMUN:FME
Watchlist
Price: 41.26 EUR 1.38%
Market Cap: €24.2B

Wall St Price Targets

FME Price Targets Summary
Fresenius Medical Care AG

Wall Street analysts forecast FME stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FME is 43.08 EUR with a low forecast of 23.12 EUR and a high forecast of 63.92 EUR.

Lowest Forecast
Price Target
23.12 EUR
44% Downside
Average Forecast
Price Target
43.08 EUR
4% Upside
Highest Forecast
Price Target
63.92 EUR
55% Upside
Fresenius Medical Care AG Competitors:
Price Targets
BLFS
BioLife Solutions Inc
17% Upside
APO
Apollo Global Management Inc
29% Upside
BMRN
Biomarin Pharmaceutical Inc
54% Upside
ALG
Alamo Group Inc
24% Upside

Revenue
Forecast

5% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
5% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 8 years is 4%.

Gross Profit
Forecast

2% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
2% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 8 years is 5%.

Operating Income
Forecast

0% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
0% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 8 years is 8%.

Pre-Tax Income
Forecast

0% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
0% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 0%. The projected CAGR for the next 3 years is 12%.

Net Income
Forecast

0% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
0% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 8 years is 8%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is FME's stock price target?
Price Target
43.08 EUR

According to Wall Street analysts, the average 1-year price target for FME is 43.08 EUR with a low forecast of 23.12 EUR and a high forecast of 63.92 EUR.

What is the Revenue forecast for Fresenius Medical Care AG?
Projected CAGR
4%

Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 8 years is 4%.

What is the Gross Profit forecast for Fresenius Medical Care AG?
Projected CAGR
5%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 8 years is 5%.

What is the Operating Income forecast for Fresenius Medical Care AG?
Projected CAGR
8%

Over the last 13 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 8 years is 8%.

What is the Pre-Tax Income forecast for Fresenius Medical Care AG?
Projected CAGR
12%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 0%. The projected CAGR for the next 3 years is 12%.

What is the Net Income forecast for Fresenius Medical Care AG?
Projected CAGR
8%

Over the last 13 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 8 years is 8%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett